drug
mebufotenin
Phase 2updated 3mo agoby $ATAI AtaiBeckley Inc.
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
News(1)
- Lilly to buy AtaiBeckley for $2.8B, further validating psychedelicsThe latest in a prolific streak of buyouts by Lilly is the strongest sign yet that large pharmaceutical companies may finally be embracing a long-dismissed field of research.biopharma_dive · 1mo ago
Data sources
last refreshed 1m ago
Found something off?
comments(0)
5-min edit window · permanent after that